In addition, in a recent study, NOX4 expression was observed in thyroid cancer and in papillary thyroid cancer (PTC)-derived mesenchymal stem/stromal cells (MSCs) (275), thus indicating a paracrine role for NADPH oxidase NOX4 in thyroid function. This evidence concerns the gene FMO5 and thyroid gland carcinoma.